Brief: Medistim Transfers 8000 Shares To CEO's Company K2 Consulting
April 3 (Reuters) - Medistim ASA MEDI.OL :
* HAS TRANSFERRED 8000 SHARES TO CEO KARI KROGSTAD'S 100%
OWNED
COMPANY K2 CONSULTING
* AVERAGE SHARE PRICE NOK 193 PER SHARE
Source text for Eikon: ID:nObiqx4hXa
Further company coverage: MEDI.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))